Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival
- PMID: 15701852
Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival
Abstract
Current diagnosis of renal cancer consists of histopathologic examination of tissue sections and classification into tumor stages and grades of malignancy. Until recently, molecular differences between tumor types were largely unknown. To examine such differences, we did gene expression measurements of 112 renal cell carcinoma and normal kidney samples on renal cell carcinoma-specific cDNA microarrays containing 4,207 genes and expressed sequence tags. The gene expression patterns showed deregulation of complete biological pathways in the tumors. Many of the molecular changes corresponded well to the histopathologic tumor types, and a set of 80 genes was sufficient to classify tumors with a very low error rate. Distinct gene expression signatures were associated with chromosomal abnormalities of tumor cells, metastasis formation, and patient survival. The data highlight the benefit of microarrays to detect novel tumor classes and to identify genes that are associated with patient variables and tumor properties.
Similar articles
-
Gene signatures of progression and metastasis in renal cell cancer.Clin Cancer Res. 2005 Aug 15;11(16):5730-9. doi: 10.1158/1078-0432.CCR-04-2225. Clin Cancer Res. 2005. PMID: 16115910
-
Differential gene expression identifies subgroups of renal cell carcinoma.J Lab Clin Med. 2006 May;147(5):250-67. doi: 10.1016/j.lab.2006.04.001. J Lab Clin Med. 2006. PMID: 16697773
-
Gene expression profiling predicts survival in conventional renal cell carcinoma.PLoS Med. 2006 Jan;3(1):e13. doi: 10.1371/journal.pmed.0030013. Epub 2005 Dec 6. PLoS Med. 2006. PMID: 16318415 Free PMC article.
-
Transcription profiling of renal cell carcinoma.Verh Dtsch Ges Pathol. 2002;86:153-64. Verh Dtsch Ges Pathol. 2002. PMID: 12647365 Review.
-
[DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].Klin Onkol. 2009;22(5):202-9. Klin Onkol. 2009. PMID: 19886357 Review. Czech.
Cited by
-
Genetic Analysis Identifies the Role of HLF in Renal Cell Carcinoma.Cancer Genomics Proteomics. 2020 Nov-Dec;17(6):827-833. doi: 10.21873/cgp.20236. Cancer Genomics Proteomics. 2020. PMID: 33099483 Free PMC article.
-
From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.Mol Cancer. 2009 Mar 17;8:20. doi: 10.1186/1476-4598-8-20. Mol Cancer. 2009. PMID: 19291329 Free PMC article. Review.
-
Comprehensive assessment gene signatures for clear cell renal cell carcinoma prognosis.Medicine (Baltimore). 2018 Nov;97(44):e12679. doi: 10.1097/MD.0000000000012679. Medicine (Baltimore). 2018. PMID: 30383629 Free PMC article.
-
Basic research in kidney cancer.Eur Urol. 2011 Oct;60(4):622-33. doi: 10.1016/j.eururo.2011.06.048. Epub 2011 Jul 5. Eur Urol. 2011. PMID: 21741760 Free PMC article. Review.
-
NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE element.Nucleic Acids Res. 2006;34(21):6158-69. doi: 10.1093/nar/gkl834. Epub 2006 Nov 6. Nucleic Acids Res. 2006. PMID: 17088287 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical